PFIZER LTD. - 500680 - Board recommends Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2022, inter alia, have recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the financial year ended March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022. PFIZER LTD. - 500680 - Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2022 - Outcome Of Board Meeting - Regulation 30.
Pursuant to Regulation 33 of the SEBI (Listing Obligation Disclosure Requirements) Regulations, 2015, we submit herewith audited financial results for the financial year ended March 31, 2022, Statement of Assets and Liabilities as on March 31, 2022, Statement of Audited Cash Flows for the year ended March 31, 2022, Declaration with respect to Audit Report with unmodified opinion and the Auditor''s Report by Auditors, M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 5.00 p.m. and concluded at 7.15 p.m. The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022. CDC urges Pfizer booster for children aged 5 to 11
The extra shot is expected to shore up protection for the age group as infections once again are on the rise 
From storage to transport, hurdles to getting Covid vaccine to N Koreans
North Korea has not responded to offers of aid from South Korea and international vaccine-sharing programmes, but prefers U.S.-made Moderna and Pfizer over China's Sinovac orUK's Astrazeneca shots
Pfizer prevented over 1 lakh deaths in 2021: Research
The research published by the Journal of Medical Economics revealed that the vaccine could have saved around $30.4 billion in healthcare costs. PFIZER LTD. - 500680 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Fourth COVID-19 vaccine dose provides strong immunity boost: UK study
The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received Pfizer as a third dose. PFIZER LTD. - 500680 - Board to consider FY22 results & Dividend on May 20, 2022
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 20, 2022, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2022, and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2022.Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders", the Trading Window of the Company was closed from March 31, 2022 (close of business) till 48 hours after the results are made public on May 20, 2022. PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For Consideration And To Take On Record The Audited Financial Results For The Financial Year Ended March 31, 2022.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 ,inter alia, to consider and approve a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 20, 2022, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2022, and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2022. Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders", the Trading Window of the Company was closed from Thursday, March 31, 2022 (close of business) till 48 hours after the results are made public on May 20, 2022. We request you to kindly take the same on record.